vs
Side-by-side financial comparison of PCB BANCORP (PCB) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
PCB BANCORP is the larger business by last-quarter revenue ($29.2M vs $20.4M, roughly 1.4× Sight Sciences, Inc.). On growth, PCB BANCORP posted the faster year-over-year revenue change (11.3% vs 6.9%). PCB BANCORP produced more free cash flow last quarter ($24.4M vs $-2.0M). Over the past eight quarters, PCB BANCORP's revenue compounded faster (10.4% CAGR vs 2.9%).
PCB Bank is an American community bank that focuses on the Korean-American community based in California and offers commercial banking services. It has branches in 8 states and is the third largest Korean American Bank after Bank of Hope and Hanmi Bank.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
PCB vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $29.2M | $20.4M |
| Net Profit | — | $-4.2M |
| Gross Margin | — | 87.3% |
| Operating Margin | 45.0% | -18.0% |
| Net Margin | — | -20.4% |
| Revenue YoY | 11.3% | 6.9% |
| Net Profit YoY | — | 64.9% |
| EPS (diluted) | $0.65 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $29.2M | $20.4M | ||
| Q3 25 | $30.4M | $19.9M | ||
| Q2 25 | $29.3M | $19.6M | ||
| Q1 25 | $26.9M | $17.5M | ||
| Q4 24 | $26.2M | $19.1M | ||
| Q3 24 | $25.3M | $20.2M | ||
| Q2 24 | $24.2M | $21.4M | ||
| Q1 24 | $23.9M | $19.3M |
| Q4 25 | — | $-4.2M | ||
| Q3 25 | $11.4M | $-8.2M | ||
| Q2 25 | $9.1M | $-11.9M | ||
| Q1 25 | $7.7M | $-14.2M | ||
| Q4 24 | — | $-11.8M | ||
| Q3 24 | $7.8M | $-11.1M | ||
| Q2 24 | $6.3M | $-12.3M | ||
| Q1 24 | $4.7M | $-16.3M |
| Q4 25 | — | 87.3% | ||
| Q3 25 | — | 86.4% | ||
| Q2 25 | — | 84.8% | ||
| Q1 25 | — | 86.2% | ||
| Q4 24 | — | 86.8% | ||
| Q3 24 | — | 83.9% | ||
| Q2 24 | — | 85.8% | ||
| Q1 24 | — | 85.5% |
| Q4 25 | 45.0% | -18.0% | ||
| Q3 25 | 52.3% | -39.7% | ||
| Q2 25 | 43.3% | -59.6% | ||
| Q1 25 | 40.2% | -79.2% | ||
| Q4 24 | 39.3% | -62.5% | ||
| Q3 24 | 42.2% | -55.7% | ||
| Q2 24 | 36.3% | -59.2% | ||
| Q1 24 | 27.2% | -76.4% |
| Q4 25 | — | -20.4% | ||
| Q3 25 | 37.5% | -41.0% | ||
| Q2 25 | 31.0% | -61.0% | ||
| Q1 25 | 28.8% | -80.8% | ||
| Q4 24 | — | -62.1% | ||
| Q3 24 | 30.8% | -54.9% | ||
| Q2 24 | 25.9% | -57.7% | ||
| Q1 24 | 19.6% | -84.4% |
| Q4 25 | $0.65 | $-0.07 | ||
| Q3 25 | $0.78 | $-0.16 | ||
| Q2 25 | $0.62 | $-0.23 | ||
| Q1 25 | $0.53 | $-0.28 | ||
| Q4 24 | $0.46 | $-0.23 | ||
| Q3 24 | $0.52 | $-0.22 | ||
| Q2 24 | $0.43 | $-0.25 | ||
| Q1 24 | $0.33 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $207.1M | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $390.0M | $63.9M |
| Total Assets | $3.3B | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $207.1M | $92.0M | ||
| Q3 25 | $369.5M | $92.4M | ||
| Q2 25 | $263.6M | $101.5M | ||
| Q1 25 | $214.3M | $108.8M | ||
| Q4 24 | $198.8M | $120.4M | ||
| Q3 24 | $193.1M | $118.6M | ||
| Q2 24 | $177.6M | $118.2M | ||
| Q1 24 | $239.8M | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $390.0M | $63.9M | ||
| Q3 25 | $384.5M | $64.3M | ||
| Q2 25 | $376.5M | $70.0M | ||
| Q1 25 | $370.9M | $77.6M | ||
| Q4 24 | $363.8M | $87.5M | ||
| Q3 24 | $362.3M | $95.0M | ||
| Q2 24 | $353.5M | $101.6M | ||
| Q1 24 | $350.0M | $109.2M |
| Q4 25 | $3.3B | $115.3M | ||
| Q3 25 | $3.4B | $116.3M | ||
| Q2 25 | $3.3B | $122.0M | ||
| Q1 25 | $3.2B | $129.7M | ||
| Q4 24 | $3.1B | $142.8M | ||
| Q3 24 | $2.9B | $143.6M | ||
| Q2 24 | $2.9B | $149.7M | ||
| Q1 24 | $2.9B | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.6M | $-1.8M |
| Free Cash FlowOCF − Capex | $24.4M | $-2.0M |
| FCF MarginFCF / Revenue | 83.6% | -9.7% |
| Capex IntensityCapex / Revenue | 7.5% | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $46.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.6M | $-1.8M | ||
| Q3 25 | $16.4M | $-8.7M | ||
| Q2 25 | $4.9M | $-7.5M | ||
| Q1 25 | $2.3M | $-11.6M | ||
| Q4 24 | $39.0M | $-3.5M | ||
| Q3 24 | $11.9M | $362.0K | ||
| Q2 24 | $14.6M | $-9.5M | ||
| Q1 24 | $8.2M | $-9.8M |
| Q4 25 | $24.4M | $-2.0M | ||
| Q3 25 | $16.2M | $-8.9M | ||
| Q2 25 | $3.8M | $-7.8M | ||
| Q1 25 | $1.6M | — | ||
| Q4 24 | $34.9M | $-3.6M | ||
| Q3 24 | $11.9M | $311.0K | ||
| Q2 24 | $12.8M | $-9.5M | ||
| Q1 24 | $6.0M | $-9.9M |
| Q4 25 | 83.6% | -9.7% | ||
| Q3 25 | 53.2% | -44.7% | ||
| Q2 25 | 13.1% | -39.6% | ||
| Q1 25 | 6.0% | — | ||
| Q4 24 | 133.2% | -18.9% | ||
| Q3 24 | 46.8% | 1.5% | ||
| Q2 24 | 53.1% | -44.7% | ||
| Q1 24 | 25.2% | -51.4% |
| Q4 25 | 7.5% | 0.8% | ||
| Q3 25 | 0.8% | 0.9% | ||
| Q2 25 | 3.7% | 1.1% | ||
| Q1 25 | 2.8% | 0.0% | ||
| Q4 24 | 15.5% | 0.7% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 7.3% | 0.4% | ||
| Q1 24 | 9.3% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 2.33× | — | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PCB
Segment breakdown not available.
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
